Recruiting NA Primary Dysmenorrhea (PD)

New treatment option for Primary Dysmenorrhea (PD)

Official title Graded Motor Imagery for Primary Dysmenorrhea

ClinicalTrials.gov ID: NCT07618832

What this study is testing

What it's testing
The goal of this clinical trial is to learn if graded motor imagery can reduce pain sensitivity and period pain in women with primary dysmenorrhea (painful periods with no medical cause). The main questions it aims to answer are: 1.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 30, women only

You may be able to join if

  • Female sex (aged 18-30 years)
  • Diagnosis of primary dysmenorrhea confirmed by a physician (painful menstruation for ≥6 consecutive cycles, in the absence of identifiable pelvic...
  • Pain ≥4/10 NRS experienced during the last period.
  • Confirmed altered pressure pain threshold: PPT ≥2 standard deviations below published norms for age-matched healthy women, measured at baseline...
  • Regular menstrual cycle (21-35 days)

You likely can't join if

  • Secondary dysmenorrhea (endometriosis, adenomyosis, fibroids, pelvic inflammatory disease, ovarian cysts ≥3 cm confirmed on imaging)
  • Current use of hormonal contraceptives (which alter prostaglandin levels and pain processing)
  • Pregnancy or lactation
  • Concurrent chronic pain condition (fibromyalgia, CRPS, chronic low back pain, chronic pelvic pain unrelated to menstruation)
  • Neurological or psychiatric disorder that would impair motor imagery ability (stroke, schizophrenia, active psychosis)
  • Cognitive impairment affecting informed consent capacity
See the full eligibility criteria
Who can join
  • Female sex (aged 18-30 years)
  • Diagnosis of primary dysmenorrhea confirmed by a physician (painful menstruation for ≥6 consecutive cycles, in the absence of identifiable pelvic pathology on clinical and/or ultrasound evaluation)
  • Pain ≥4/10 NRS experienced during the last period.
  • Confirmed altered pressure pain threshold: PPT ≥2 standard deviations below published norms for age-matched healthy women, measured at baseline assessment
  • Regular menstrual cycle (21-35 days)
  • Capable of engaging in virtual video sessions and taking online tests.
  • Consent to withhold new analgesic or hormonal treatments during the study period.
What rules you out
  • Secondary dysmenorrhea (endometriosis, adenomyosis, fibroids, pelvic inflammatory disease, ovarian cysts ≥3 cm confirmed on imaging)
  • Current use of hormonal contraceptives (which alter prostaglandin levels and pain processing)
  • Pregnancy or lactation
  • Concurrent chronic pain condition (fibromyalgia, CRPS, chronic low back pain, chronic pelvic pain unrelated to menstruation)
  • Neurological or psychiatric disorder that would impair motor imagery ability (stroke, schizophrenia, active psychosis)
  • Cognitive impairment affecting informed consent capacity
  • Participation in another clinical trial within 4 weeks before enrollment
  • Previous exposure to graded motor imagery or mirror therapy
  • Regular use of NSAIDs or opioids for non-menstrual indications

The study team makes the final eligibility decision.

Where it's taking place

  • Lahore, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 30 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.